Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Fasturtec
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 184
2019 Revenue in Millions : 0
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 167
2020 Revenue in Millions : 166
Growth (%) : 0
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 194
2021 Revenue in Millions : 167
Growth (%) : 16
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 183
2022 Revenue in Millions : 194
Growth (%) : -4
LOOKING FOR A SUPPLIER?